Used as an intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting central nervous system disorders. Its structure supports binding to specific enzyme or receptor sites, making it valuable in drug development for psychiatric or neurological conditions. The presence of trifluoromethyl and pyrrolidine groups enhances metabolic stability and bioavailability, which are advantageous in creating potent, long-acting therapeutics. Commonly employed in research settings for optimizing lead compounds in medicinal chemistry programs.